Clinical Trial Update: Safety and Immunogenicity Study of Recombinant Trivalent Rotavirus Subunit Vaccine in Healthy Infants and Toddlers [Phase 2]

View source ↗

Summary

This clinical trial update describes a Phase 2 safety and immunogenicity study of a recombinant trivalent rotavirus subunit vaccine in healthy infants and toddl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rotavirus Gastroenteritis
• Rotavirus Infection

Drugs mentioned

• Recombinant Trivalent Rotavirus Subunit Vaccine (Rotavirus subunit vaccine (recombinant, trivalent))

Snippet

Sponsor: MAXVAX Biotechnology Limited Liability Company | Conditions: Rotavirus Infections, Rotavirus Gastroenteritis | Phase 2 | Status: ACTIVE_NOT_RECRUITING